CBD API

Brains Bio, through its wholly-owned subsidiary, BSPG Laboratories, produces a natural, non-GMO, hemp-sourced CBD API with a purity of > 99%.

Made Better

Our CBD API has 0% THC or other impurities in line with ICH guidelines and no pesticides, herbicides, heavy metals, or radioactivity.

Third Party Testing

Our CBD products undergo rigorous testing to ensure the highest quality standards. They have been independently analyzed by certified laboratories for the absence of banned substances.

BSPG Laboratory, is one of a very limited number of organizations listed on the Eudralex GMP website with an EU-GMP and GDP certificate for CBD which is authorized for use in both human and veterinary medicinal products.

BSPG is also registered with the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) as an API manufacturer.

API (Active Pharmaceutical Ingredient)

The product produced at BSPG’s EU-GMP facility follows ICH Q7 regulations and is entitled to use as an active pharmaceutical ingredient (API) in clinical research and therapeutic drug and product development.

Exclusive Partnership with Royal DSM

Meeting these strict manufacturing and compliance standards, together with our exclusive partnership with world-leader Royal DSM, has enabled Brains to access multiple geographies around the world, including the UK, Brazil, Austria, the USA and Australia.

Brains Bio has an exclusive commercialization partnership with Royal DSM for the sale of CBD API for prescription pharmaceuticals. Royal DSM is a purpose-led science-based multinational corporation active in the research, development, manufacture, marketing and sale of ingredients for the animal nutrition, human nutrition, pharmaceutical and cosmetic industries. DSM has over 21,000 employees globally, a market capitalization exceeding 30 billion Euro.

Jas Kalsi

An experienced Chartered Professional Accountant with over 30 years of experience in providing personal and corporate taxation, corporate restructuring, financing, public offering and human resources management services. Kalsi is the Chief Financial Officer for Brains Bioceutical Corp., a global manufacturer of naturally-sourced active pharmaceutical ingredients (APIs). In this role, Kalsi is responsible for overseeing and managing the fiscal health of the group, implementing best practices with respect to finance, accounting and internal controls, obtaining funding, providing recommendations on mergers and acquisitions and working collaboratively with the CEO and Board of Directors on strategy. In addition, Kalsi will be responsible to regulatory entities and authorities, including any security exchange commissions.

Kalsi was an audit partner at KPMG focusing on small, medium and large private, government sector and public audit clients. He was the Human Resource Manager in charge of recruiting, staff development and training, and a member of KPMG’s Professional Practice Group. Subsequent to KPMG, Kalsi was the Chief Financial Officer / Chief Executive Officer of a variety of private companies including 6.5 years with a pharmaceutical fulfillment provider and API developer.

Kalsi has a proven track record in hiring top-level senior executives, restructuring companies to minimize tax and maximize cash flows, raising financing and creating a cohesive culture.

Kalsi has a passion for wellness and has created several initiatives and partnered with several leading-edge individuals to help people create and enjoy the best versions of themselves. He sees the use cannabinoids as a major tool to facilitate one’s optimum lifestyle.

With the team and infrastructure in place, Brains Bioceutical has quickly become an industry leader in both the nutraceutical and pharmaceutical cannabinoid industries, with several clinical trials and academic studies underway evaluating the efficacy of cannabinoids to treat major diseases. Under Kalsi’s leadership, Brains Bioceutical has already established market dominance, as it is the only company in the world to sell bulk API commercially around the world, supporting both the pharmaceutical and wellness sectors. With ambitious plans to expand Brains Bioceutical into a global biotech company specializing in cannabinoid health and wellness solutions, Kalsi is pioneering a new frontier in medicinal and wellness solutions across the world.

CBD API

Brains Bio, through its wholly-owned subsidiary, BSPG Laboratories, produces a natural, non-GMO, hemp-sourced CBD API with a purity of > 99%.

Made Better

Our CBD API has 0% THC or other impurities in line with ICH guidelines and no pesticides, herbicides, heavy metals, or radioactivity.

Third Party Testing

API (Active Pharmaceutical Ingredient)

The product produced at BSPG’s EU-GMP facility follows ICH Q7 regulations and is entitled to use as an active pharmaceutical ingredient (API) in clinical research and therapeutic drug and product development.

Exclusive Partnership with Royal DSM

Contact Us

General Inquiries:

Request Our Investor Deck:

CBD API

Brains Bio, through its wholly-owned subsidiary, BSPG Laboratories, produces a natural, non-GMO, hemp-sourced CBD API with a purity of > 99%.

Made Better

Our CBD API has 0% THC or other impurities in line with ICH guidelines and no pesticides, herbicides, heavy metals, or radioactivity.

Third Party Testing

API (Active Pharmaceutical Ingredient)

The product produced at BSPG’s EU-GMP facility follows ICH Q7 regulations and is entitled to use as an active pharmaceutical ingredient (API) in clinical research and therapeutic drug and product development.

Exclusive Partnership with Royal DSM

Contact Us

General Inquiries:

Request Our Investor Deck:

Jas Kalsi

Chief Financial Officer

Jennifer Archibald

Chief Financial Officer

Barinder Bhullar

Senior Vice President, Corporate Affairs

William Purves

Chief Commercial Officer

Gurdeep Bains

VP of Business Development

Jorja’s Story

A father’s journey to saving his daughter’s life

Dr. Mike Bowen

Dr. Jack Taunton

Dr. Sharon Gurm

Dr. David Putrino

Dr. Gerry Ramogida

Norma Sebestyen

Dean Billington

COO

Terry O’Regan

President

Rick Brar

CEO and Chairman